Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.

Recruiting N/A Interventional Study
Breast Cancer
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 99
Sex
Female
Study type
Interventional
Purpose
Supportive Care
Participants needed
300 (estimated)
Sponsor
National Cancer Centre, Singapore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

ASTER is a multi-part study that aims to prospectively establish evidence for the implementation of aromatherapy as complementary therapy within cancer care in the Singapore context. ASTER 2 study evaluates how extracts from Asian aromatic plants with familiar aromas introduced as inhalation therapy can alleviate distress in breast cancer patients scheduled to undergo radiotherapy (RT).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Aged 21 years old and above 2. Confirmed diagnosis of breast cancer of any stage 3. Scheduled to undergo radiotherapy for the first time 4. Capable of providing informed consent Exclusion Criteria: 1. Physically or mentally incapable of providing verbal/written consent 2. K…
Contacts

Dr. Fuh-Yong Wong, MBBS, FRCR

+65 63061110

wong.fuh.yong@singhealth.com.sg

CONTACT